Meda Pharmaceuticals Inc. is the U.S. subsidiary of Meda AB. Meda AB is an international specialty pharma company with its own sales organizations in close to 60 countries and operations expanding in growth markets.
Sales and marketing activities are carried out via distributors in countries where Meda has no representation. Meda's pharmaceuticals are sold in more than 120 countries.
Meda's product portfolio is divided into three main areas:
- Specialty Products
- OTC (nonprescription products)
- Branded Generics
Meda AB is the Group's parent company and its head office is in Solna, Sweden. Meda was listed in 1995 at the Stockholm stock market and since 2006 listed under Large Cap on the NASDAQ OMX Nordic Exchange in Stockholm, Sweden.
Find out more about Meda AB by visiting